Legal, Important Notices
Please Note:
The documents contained in (or directly accessible from) this website include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including (i) statements about the Company's plans to achieve certain milestones and about the Company's expected competitive advantages and (ii) any statements containing the words "believes", "expects", "anticipates", "plans", "estimates" and similar expressions. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated by such forward-looking statements, including the following: (i) we need to obtain governmental approvals, (ii) clinical trials are time-consuming and difficult to design and to implement, (iii) we are dependent on third-party manufacturers—and other vendors—over whom we have little control, (iv) our lead product candidate requires several additional processes before it is ready to an initial IND filing with the FDA, and (v) many other factors, as described in the company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.